Three Common Myths About DoxyPEP

by Robert Johnson | Mar 8, 2026 | Prevention and Risk Reduction

Sun Exposure, Birth Control, and Vaginal Infections Doxycycline post-exposure prophylaxis (DoxyPEP) is a new strategy for preventing certain bacterial sexually transmitted infections. The idea is straightforward: a person takes 200 mg of doxycycline after sex, ideally...

You’re Buying WHAT Exactly? BlueChew, Ro & Hims

by Robert Johnson | Feb 15, 2026 | Telehealth

Click Video to Watch Transcript from video (Full Video Transcript (Spoken Format Preserved) What is Blue Chew? What is Rugiet? What is Ro Spark? Well, I don’t think they’re gonna want me to tell you this, but I will anyway. If you understand the economics...

Bremelanotide: From Tanning Peptide to Cutting-Edge Arousal Therapy

by Robert Johnson | Feb 9, 2026 | Performance and Desire

What Bremelanotide Is, How It Works, and Why It Matters for Sexual Health Bremelanotide is a fascinating newer therapy with an unusual origin and a modern purpose in sexual medicine. It’s a synthetic peptide (originally known as PT-141) that acts as a melanocortin...

Apomorphine: From Century-Old Drug to Cutting-Edge ED Therapy

by Robert Johnson | Feb 4, 2026 | Performance and Desire

If you’re here because you’re considering treatment and want to understand how this medication actually works, you’re in the right place. You don’t need to read everything — this page is here so you can make a confident decision. You can skim the bold sections, read...

The Truth About Addyi: Why There’s No Pill That Fixes Sexual Desire

by Robert Johnson | Jan 20, 2026 | Menopause and Women's Health

So what is Addyi? Addyi actually began its life as an antidepressant developed by Boehringer Ingelheim. It failed as an antidepressant, but researchers noticed that in some women, it appeared to increase sexual desire as a side effect. Boehringer attempted to get it...